The management, early and one year outcome in hospitalized patients with heart failure: A national heart failure survey in Israel - HFSIS 2003

Israel Medical Association Journal

Volumn 9, Issue 4, 2007, Pages 227-233

  Garty, Moshe ^a   Shotan, Avraham ^b   Gottlieb, Shmuel ^c   Mittelman, Moshe ^a   Porath, Avi ^d   Lewis, Basil S ^e   Grossman, Ehud ^f   Behar, Solomon ^f   Leor, Jonathan ^f   Green, Manfred S ^f   Zimlichman, Reuven ^g   Caspi, Abraham ^h  

^a RABIN MEDICAL CENTER   (Israel)

^b HILLEL YAFFE MEDICAL CENTER   (Israel)

^c BIKUR CHOLIM HOSPITAL   (Israel)

^d BEN GURION UNIVERSITY OF THE NEGEV   (Israel)

^e Lady Davis Carmel Medical ^*  (Israel)

^f MINISTRY OF HEALTH   (Israel)

^g WOLFSON MEDICAL CENTER   (Israel)

^h KAPLAN MEDICAL CENTER   (Israel)

Author keywords

Heart failure; One year mortality; Prognosis

Indexed keywords

ACETYLSALICYLIC ACID; ALDOSTERONE ANTAGONIST; AMIODARONE; ANGIOTENSIN RECEPTOR ANTAGONIST; ANTICOAGULANT AGENT; ANTITHROMBOCYTIC AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; CLOPIDOGREL; CREATININE; DIGOXIN; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; FUROSEMIDE; HEMOGLOBIN; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; INOTROPIC AGENT; NITRIC ACID DERIVATIVE; THIAZIDE DIURETIC AGENT; VASODILATOR AGENT;

ADULT; ANEMIA; ARTICLE; CARDIOLOGY; CHRONIC OBSTRUCTIVE LUNG DISEASE; CORONARY ARTERY DISEASE; CREATININE BLOOD LEVEL; DIABETES MELLITUS; DISEASE SEVERITY; DYSLIPIDEMIA; FEMALE; HEALTH SURVEY; HEART ATRIUM FIBRILLATION; HEART FAILURE; HOSPITAL DISCHARGE; HOSPITALIZATION; HUMAN; HYPERTENSION; INTERNAL MEDICINE; ISRAEL; KIDNEY FAILURE; MAJOR CLINICAL STUDY; MALE; MORTALITY; MULTIVARIATE LOGISTIC REGRESSION ANALYSIS; OUTCOME ASSESSMENT; PATIENT CARE; PROCESS DEVELOPMENT; PROGNOSIS; PUBLIC HOSPITAL; RISK FACTOR;

AGE DISTRIBUTION; AGED; ECHOCARDIOGRAPHY; FEMALE; FOLLOW-UP STUDIES; HEART CATHETERIZATION; HEART FAILURE, CONGESTIVE; HOSPITAL MORTALITY; HUMANS; INPATIENTS; ISRAEL; MALE; MIDDLE AGED; PROGNOSIS; PROSPECTIVE STUDIES; SEVERITY OF ILLNESS INDEX; SEX DISTRIBUTION; TIME FACTORS;

EID: 34247857539     PISSN: 15651088     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (25)

1. Swedberg K, Cleland J, Dargie H, et al., for the Task Force for the Diagnosis and Treatment of Chronic Heart Failure of the European Society of Cardiology. Guidelines for the diagnosis and treatment of chronic heart failure: executive summary (update 2005). Eur Heart J 2005;26:1115-40.
2. Nieminen MS, Bohm M, Cowie MR, et al., for the Task Force on Acute Heart Failure of the European Society of Cardiology. Executive summary of the guidelines on the diagnosis and treatment of acute heart failure. Guidelines on the diagnosis and treatment of acute heart failure. Eur Heart J 2005;26:384-416.
3. A report of the American College of Cardiology/American Heart Association task force on practice guidelines (writing committee to update the 2001 guidelines for the evaluation and management of heart failure). Hunt SA (Chair): ACC/AHA guidelines update for the diagnosis and management of chronic heart failure in the adult © 2005 by the American College of Cardiology Foundation and the American Heart Association, Inc 2005:1-82.
4. Young JB. The global epidemiology of heart failure. Med Clin North Am 2004;88:1135-43.
5. Cleland JGF, Swedberg K, Follath F, et al., for the Study Group on Diagnosis of the Working Group on Heart Failure of the European Society of Cardiology. The EuroHeart Failure survey programme - survey on the quality of care among patients with heart failure in Europe. Part 1: Patient characteristics and diagnosis. Eur Heart J 2003;24:442-63.
6. Komajda M, Follath F, Swedberg K, et al., for the Study Group on Diagnosis of the Working Group on Heart Failure of the European Society of Cardiology. The EuroHeart Failure survey programme - survey on the quality of care among patients with heart failure in Europe. Part 1: Treatment. Eur Heart J 2003;24:464-74.
7. Fonarow GC, Adams K, Strauser BP. ADHERE (Acute Decompensated Heart Failure National Registry): rationale, design, and subject population. J Cardiac Fail 2002;8:S49.
8. Fonarow GC, Adams KF, Abraham WT, et al., for the ADHERE scientific advisory committee, study group and investigators. Risk stratification for in-hospital mortality in acutely decompensated heart failure: classification and regression tree analysis. JAMA 2005;293:572-80.
9. Goldberg RJ, Spencer FA, Farmer C, et al. Incidence and hospital death rates associated with heart failure: a community-wide perspective. Am J Med 2005;118:728-34.
10. Opasich C, Tavazzi L, Lucci D, Gorini M, et al., on behalf of the Italian Network on Congestive Heart Failure (IN-CHF) investigators. Comparison of one-year outcome in women versus men with chronic congestive heart failure. Am J Cardiol 2000;86:353-7.
11. Braunstein JB, Anderson GF, Gerstenblith G, et al. Noncardiac comorbidity increases preventable hospitalizations and mortality among medicare beneficiaries with chronic heart failure. J Am Coll Cardiol 2003;42:1226-33.
12. Levy D, Kenchaiah S, Larson MG, et al. Long-term trends in the incidence of and survival with heart failure. N Engl J Med 2002; 347:1397-402.
13. Jong P, Vowinckel E, Liu PP, Gong Y, Tu JV. Prognosis and determinants of survival in patients newly hospitalized for heart failure: a population based study. Arch Intern Med 2002;162:1689-94.
14. Lee DS, Austin PC, Rouleau JL, et al. Predicting mortality among patients hospitalized for heart failure: derivation and validation of a clinical model. JAMA 2003;290:2581-7.
15. Blackledge HM, Tomlinson J, Squire IB. Prognosis of patients newly admitted to hospital with heart failure: survival trends in 12,220 index admissions in Leicestershire 1993-2001. Heart 2003; 89:615-20.
16. McAlister FA, Ezerkowitz J, Tonelli M, Armstrong PW. Renal Insufficiency and heart failure: prognosis and therapeutic implications from a prospective cohort study. Circulation 2004;109:1004-9.
17. Akhter MW, Aronson D, Bitar F, et al. Effect of elevated admission serum creatinine and its worsening on outcome in hospitalized patients with decompensated heart failure. Am J Cardiol 2004; 94:957-60.
18. Horwich TB, Fonarow GC, Hamilton MA, MacLellan WR, Borenstein J. Anemia is associated with worse symptoms, greater impairment in functional capacity and a significant increase in mortality in patients with advanced heart failure. J Am Coll Cardiol 2002;39:1780-6.
19. Jessup M, Brozena S. Medical progress: heart failure. N Engl J Med 2003;348:2007-18.
20. Pitt B, Zannad F, Remme W, Cody R, et al., for the Randomized Aldactone Evaluation Study investigators. The effect of spironolactone on morbidity and mortality in patients with severe heart failure. N Engl J Med 1999;341:709-17.
21. Pitt B, Remme W, Zannad F, et al., for the Eplerenone Post-Acute Myocardial Infarction Heart Failure and Survival Study investigators. Eplerenone, a selective aldosterone blocker, in patients with left ventricular dysfunction after myocardial infarction. N Engl J Med 2003;348:1309-21.
22. Juurlink DN, Mamdani MM, Lee DS, et al. Rates of hyperkalemia after publication of the Randomized Aldactone Evaluation Study. N Engl J Med 2004;351:543-51.
23. Silver MA, Maisel A, Yancy CW, et al. DA: BNP Consensus Panel 2004. A clinical approach for the diagnostic, prognostic, screening, treatment monitoring, and therapeutic roles of natriuretic peptides in cardiovascular diseases. Congest Heart Fail 2004; 10(Suppl 3):1-30.
24. Konstam MA, for the Executive Council of Heart Failure Society of America. Heart failure training: a call for an integrative, patient-focused approach to an emerging cardiology subspecialty. J Am Coll Cardiol 2004;44:1361-2.
25. Desai S, Jessup M. Practice guidelines: role of internists and primary care physicians. Med Clin North Am 2004;88:1369-80.